A convective transport-enhanced multi-organoid device for therapeutic modeling of the liver-pancreas axis in obesity
Theranostics · 01.01.2026 · 16 (1) · 220-238
DOI: 10.7150/thno.114415 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, erschienen am 01.01.2026. Verfasst von Jisu Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering and Nano-Bioengineering, College of Life Sciences and Bioengineering, Incheon National University, Incheon, 22012, Repub…. Hauptthemen laut MEDLINE: Liver, Obesity, Organoids, Pancreas. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Rationale
Obesity-associated metabolic diseases such as metabolic dysfunction-associated steatotic liver disease (MASLD) and type 2 diabetes mellitus (T2DM) are increasing rapidly, necessitating physiologically relevant in vitro models of the liver-pancreas axis. While recent multi-organoid systems have advanced inter-organ modeling, many systems still fall short of replicating the complex and directional metabolic interactions required to accurately reflect disease progression. This is partly due to inherent limitations such as reliance on passive diffusion for metabolic exchange and the use of shared or non-compartmentalized media, which restrict tissue-specific functions and fail to mimic in vivo-like physiological gradients.
Methods
To overcome these limitations, we developed a multi-organoid device (MOD) that incorporates convective flow and physically separates liver and pancreatic organoids in distinct media environments. To evaluate the effectiveness of this co-culture system, we assessed metabolic transport using FITC-dextran and examined pancreatic and liver organoid function by measuring insulin and albumin secretion respectively. The effectiveness of the MOD in modeling MASLD-induced T2DM was further validated through functional assays and transcriptomic analysis.
Results
The MOD successfully recapitulated key pathological features of MASLD-induced T2DM. Convective flow significantly enhanced directional transport of glucose and other metabolic molecules compared to passive diffusion, as validated by simulation and diffusion assays. Media separation preserved organoid function, increasing insulin and albumin secretion by 1.8- and 1.6-fold, respectively, compared with the non-separated group. Importantly, the device achieved rapid glucose regulation following glucose stimulation, with normoglycemia restored within 2 hours closely mimicking physiological glucose regulation not previously attainable in existing systems. Under MASLD conditions, the platform further revealed that liver-derived Fetuin-A was associated with β-cell apoptosis in pancreatic organoids.
Conclusion
This MOD effectively models the pathophysiological cascade linking MASLD and T2DM by integrating organ-specific environments, convective flow, and multi-organ crosstalk. It offers a robust and biologically relevant tool for mechanistic studies of metabolic diseases and provides a promising platform for preclinical drug screening and therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering and Nano-Bioengineering, College of Life Sciences and Bioengineering, Incheon National University, Incheon, 22012, Republic of Korea.
- Department of Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.
- Center for Nanomedicine, Institute for Basic Science (IBS), Seoul, 03722, Republic of Korea.
- Cellartgen Inc., Seoul, 03722, Republic of Korea.
- Division of Bioengineering, College of Life Sciences and Bioengineering, Incheon National University, Incheon, 22012, Republic of Korea.
- Research Center for Bio Materials & Process Development, Incheon National University, Incheon, 22012, Republic of Korea.
Zitieren
APA
Kim, J., Bae, J., Cui, B., Cho, S. W., & Yang, K. (2026). A convective transport-enhanced multi-organoid device for therapeutic modeling of the liver-pancreas axis in obesity. Theranostics, 16(1), 220-238. https://doi.org/10.7150/thno.114415
Vancouver
Kim J, Bae J, Cui B, Cho SW, Yang K. A convective transport-enhanced multi-organoid device for therapeutic modeling of the liver-pancreas axis in obesity. Theranostics. 2026;16(1):220-238. doi:10.7150/thno.114415
BibTeX
@article{Kim2026,
author = {Kim, Jisu and Bae, Jungho and Cui, Baofang and Cho, Seung-Woo and Yang, Kisuk},
title = {A convective transport-enhanced multi-organoid device for therapeutic modeling of the liver-pancreas axis in obesity},
journal = {Theranostics},
year = {2026},
volume = {16},
number = {1},
pages = {220--238},
doi = {10.7150/thno.114415}
}
EUVIMED